A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel
2 other identifiers
interventional
40
1 country
4
Brief Summary
The purpose of this randomized controlled trial is to compare the efficacy and potential biological mechanisms of action of 10 sessions of a web-version of Prolonged Exposure (PE), "Web-PE," delivered over 8-weeks to 10 sessions of Present Centered Treatment (PCT) delivered over 8-weeks by a therapist in 120 active duty military personnel with PTSD. Up to 170 individuals will be consented to obtain data from 120 for analysis. Participants will be assessed at pre-treatment, mid-treatment, and 1-, 3- and 6-months after treatment completion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2016
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 24, 2015
CompletedFirst Posted
Study publicly available on registry
September 22, 2015
CompletedStudy Start
First participant enrolled
May 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedSeptember 9, 2019
September 1, 2019
2.1 years
July 24, 2015
September 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
To evaluate the efficacy of Web-PE relative to PCT in the reduction of PTSD severity (using the CAPS severity score).
Three years
To evaluate the efficacy of Web-PE relative to PCT in the reduction in associated psychopathology
Associated psychopathology: PTSD diagnosis and severity scores on measures of depression, general anxiety, anger, and PTSD-related cognitions
Three years
To evaluate the efficacy of Web-PE relative to PCT in the change in associated biomarkers
i.e., Cortisol response to awakening, cortisol response to script-driven imagery, salivary and serum neurosteroids.
Three years
Secondary Outcomes (1)
Composite ratings on the use of the Web-PE program
Three years
Study Arms (2)
Web-PE
EXPERIMENTALTen 60-minute psychotherapy sessions over 8 weeks, focused on gradually confronting distressing trauma-related memories and reminders. Web-PE is an internet-based version of prolonged exposure (PE) for posttraumatic stress disorder (PTSD).
PCT
ACTIVE COMPARATORTen 60-minute psychotherapy sessions over 8 weeks, focused on identifying and solving day-to-day problems as they are brought up by the participants. PCT is a manualized therapy that has been used as active control condition in several CBT studies.
Interventions
Ten 60-minute psychotherapy sessions over 8 weeks, focused on gradually confronting distressing trauma-related memories and reminders. Web-PE is an internet-based version of prolonged exposure (PE) for posttraumatic stress disorder (PTSD).
Ten 60-minute psychotherapy sessions over 8 weeks, focused on identifying and solving day-to-day problems as they are brought up by the participants. PCT is a manualized therapy that has been used as active control condition in several CBT studies. It provides a credible comparison therapy to control for nonspecific therapeutic factors so that observed effects of Web-PE can be attributed to its specific ingredients beyond the benefits of good therapy.
Eligibility Criteria
You may qualify if:
- Adult male and female active duty military personnel or veterans who have deployment since 9/11, ages 18-65 seeking treatment for PTSD. Veterans must be eligible for military medical care on Fort Hood.
- Diagnosis of PTSD as determined by a Clinician Administered PTSD Scale for DSM-5 (CAPS-5) clinical interview score ≥ 25. Person has experienced a Criterion A event that is a specific combat-related event or high magnitude operational experience that occurred during a period of recent military deployment. The diagnosis of PTSD may be indexed to that event or to another Criterion A event.
- Able to speak and read English
- Indication that the participant plans to be in the area for the next five months following the first assessment
You may not qualify if:
- Recent manic episode (past 12 months) or a psychotic disorder (as determined by the bipolar and psychosis sections of the MINI)
- Current alcohol dependence (as determined by an a score of ≥ 4 on items #4-6 and a total score of ≥20 on the AUDIT)
- Evidence of a moderate or severe traumatic brain injury (as determined by the inability to comprehend the baseline screening questionnaires)
- Current suicidal ideation severe enough to warrant immediate attention (as determined by the Depressive Symptoms Index-Suicidality Subscale and corroborated by a clinical risk assessment by a credentialed provider)
- Other psychiatric disorders severe enough to warrant designation as the primary disorder
- Recent course of PE within the past 12 months
- Currently engaged in evidence-based treatment for PTSD (e.g. Prolonged Exposure Therapy or Cognitive Processing Therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- University of Texascollaborator
- VA Palo Alto Health Care Systemcollaborator
Study Sites (4)
Department of Psychiatry and Behavioral Sciences, Emory University
Atlanta, Georgia, 30322, United States
Center for the Treatment and Study of Anxiety, University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Carl R. Darnall Army Medical Center
Killeen, Texas, 76544, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carmen McLean, Ph.D.
University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Sheila Rauch, Ph.D.
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 24, 2015
First Posted
September 22, 2015
Study Start
May 1, 2016
Primary Completion
June 1, 2018
Study Completion
August 1, 2019
Last Updated
September 9, 2019
Record last verified: 2019-09